Termination of Gender-Affirming Care Grants at the National Institutes of Health
JAMA Pediatrics · 01.01.2026 · 180 (1) · 83
DOI: 10.1001/jamapediatrics.2025.4653 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Pediatrics, erschienen am 01.01.2026. Verfasst von Amitai S Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: National Institutes of Health (U.S.), Financing, Government, Transgender Persons, Research Support as Topic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Gender-affirming care (GAC) improves the mental health and well-being of transgender and gender-diverse people. In January 2025, the Trump administration announced major National Institutes of Health (NIH) grant terminations, specifically aimed at defunding research related to transgender populations.
Objective
To examine the scope, timing, and financial impact of NIH GAC grant terminations. Design, Setting, and Participants This was a cross-sectional study of terminated and active federal research grants administered by the NIH, identified through the Grant Witness and NIH RePORTER databases. Inclusion criteria required that grants involve GAC outcomes or research related to its access or provision. Data were collected on May 12, 2025, and included funding status, dates of termination, and grant characteristics. Exposure Termination of NIH grants related to GAC. Main Outcomes and Measures Primary outcomes included the number and proportion of terminated grants, total funding lost, date of termination, and study focus.
Results
Of 64 identified NIH grants related to GAC, 41 (64.1%) were terminated within a 3-week span ranging from March 3 to March 21, 2025. Among these terminated grants, 46.9% of their combined funding remained unspent at the time of cancellation, amounting to nearly $22 million lost in research dollars. Of the research topics that were terminated, the largest proportion focused on the interaction of GAC with physical health conditions (eg, breast cancer, HIV, cardiovascular outcomes). Conclusions and Relevance Findings of this study illustrate the scope and depth of a targeted disruption to a vital area of scientific inquiry and health equity, emphasizing the need for insulated funding streams to preserve ongoing GAC research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Harvard Medical School, Boston, Massachusetts.
- Harvard University John F. Kennedy School of Government, Cambridge, Massachusetts.
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Division of Plastic and Reconstructive Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Division of Plastic and Reconstructive Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston.
- Department of Psychiatry, Massachusetts General Hospital, Boston.
Zitieren
APA
Miller, A. S., Liu, M., Graham, R., Berlin, N. L., Carruthers, K. H., & Keuroghlian, A. S. (2026). Termination of Gender-Affirming Care Grants at the National Institutes of Health. JAMA Pediatrics, 180(1), 83. https://doi.org/10.1001/jamapediatrics.2025.4653
Vancouver
Miller AS, Liu M, Graham R, Berlin NL, Carruthers KH, Keuroghlian AS. Termination of Gender-Affirming Care Grants at the National Institutes of Health. JAMA Pediatrics. 2026;180(1):83. doi:10.1001/jamapediatrics.2025.4653
BibTeX
@article{Miller2026,
author = {Miller, Amitai S and Liu, Michael and Graham, Rita and Berlin, Nicholas L and Carruthers, Katherine H and Keuroghlian, Alex S},
title = {Termination of Gender-Affirming Care Grants at the National Institutes of Health},
journal = {JAMA Pediatrics},
year = {2026},
volume = {180},
number = {1},
pages = {83},
doi = {10.1001/jamapediatrics.2025.4653}
}
EUVIMED